Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Biomarin Pharmaceutical Inc
Biomarin Pharmaceutical Inc_20100114
Biomarin Pharmaceutical Inc_20100121
  

Biomarin Pharmaceutical Inc patents

Recent patent applications related to Biomarin Pharmaceutical Inc. Biomarin Pharmaceutical Inc is listed as an Agent/Assignee. Note: Biomarin Pharmaceutical Inc may have other listings under different names/spellings. We're not affiliated with Biomarin Pharmaceutical Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Biomarin Pharmaceutical Inc-related inventors




Date Biomarin Pharmaceutical Inc patents (updated weekly) - BOOKMARK this page
11/09/17Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
06/29/17Delivery of therapeutic compounds to the brain and other tissues
04/06/17Adeno-associated virus factor viii vectors
03/30/17Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same
02/23/17Histone deacetylase inhibitors
02/23/17Variants of c-type natriuretic peptide
02/16/17Use of tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders
02/16/17Histone deacetylase inhibitors
02/02/17Use of c-type natriuretic peptide variants to treat skeletal dysplasia
01/12/17Lysosomal targeting peptides and uses thereof
01/05/17Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
12/22/16Methods and compositions for the treatment of metabolic disorders
12/15/16Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
11/10/16Tpp-1 formulations and methods for treating cln2 disease
09/29/16N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
09/29/16Triazole intermediates useful in the synthesis of protected n-alkyltriazolecarbaldehydes
09/08/16Variants of c-type natriuretic peptide
08/11/16Glucosylceramide synthase inhibitors for the treatment of diseases
07/14/16Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
06/30/16Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof
06/02/16Targeted therapeutic proteins
06/02/16Quantification of non-reducing end glycan residual compounds for determinging the presence, identity, or severity of a disease or condition
05/19/16Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
05/05/16Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
03/17/16Dry blend formulation of tetrahydrobiopterin
02/11/16Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
02/04/16Hdac inhibitors
02/04/16Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
02/04/16Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
02/04/16Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
10/29/15Detection of oligosaccharides
07/30/15Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
07/30/15Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) for use in treatment of diseases associated with a pten deficiency
06/11/15Histone deacetylase inhibitors
06/04/15Delivery of therapeutic compounds to the brain and other tissues
03/12/15Adeno-associated virus factor viii vectors
03/05/15Lysosomal targeting peptides and uses thereof
03/05/15Targeted therapeutic proteins
11/20/14Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof
10/30/14Processes of synthesizing dihydropyridophthalazinone derivatives
08/14/14Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
06/12/14Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
03/06/14Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) for use in treatment of diseases associated with a pten deficiency
09/26/13Cyp11b, cyp17, and/or cyp21 inhibitors
09/12/13Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
09/12/13Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
07/25/13Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
05/02/13Dry blend formulation of tetrahydrobiopterin
02/28/13Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
02/14/13Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
12/13/12Variants of c-type natriuretic peptide
11/22/12Targeted therapeutic proteins
10/04/12Novel semi-synthetic glycopeptides as antibacterial agents
08/23/12Lysosomal targeting peptides and uses thereof
08/16/12Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
07/26/12Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof
06/14/12Formulations for lysosomal enzymes
06/14/12Delivery of therapeutic compounds to the brain and other tissues
06/07/12Targeted therapeutic proteins
05/24/12Novel semi-synthetic glycopeptides as antibacterial agents
05/24/12Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
05/03/12Methods and compositions for the treatment of metabolic disorders
04/19/12Methods for treating pompe disease
01/26/12Pterin analogs
11/17/11Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
Patent Packs
08/18/11Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
07/21/11Novel cyp17 inhibitors
12/30/10Variants of c-type natriuretic peptides
11/25/10Variants of c-type natriuretic peptide
11/04/10Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
10/14/10Methods of enhancing yield of active iga protease
05/27/10Methods and compositions for the treatment of pulmonary hypertension of the newborn
05/06/10Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
04/15/10Pterin analogs
03/18/10Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
01/21/10Pterin analogs
01/14/10Methods and compositions for the treatment of metabolic disorders
01/14/10Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrug
10/22/09Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
09/24/09Induction of antigen specific immunnologic tolerance
Patent Packs
08/06/09Method of synthesizing tetrahydrobiopterin
07/30/09Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
07/23/09Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
07/09/09Pterin analogs
02/19/09Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
02/19/09Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
01/21/10Pterin analogs
01/14/10Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrug







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Biomarin Pharmaceutical Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Biomarin Pharmaceutical Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';